Valneva Spies Chance To Join Third Wave Of COVID-19 Vaccines
Boosted By UK Vaccine Taskforce Payments
The company is hoping for strong efficacy from its inactivated vaccine, boosted by two adjuvants
You may also be interested in...
Days after inking a COVID-19 collaboration with Dynavax, Valneva has linked up with Pfizer to drive its Lyme disease vaccine VLA15 towards Phase III trials.
A rush of additional orders from countries around the world has boosted the company’s prospects, and fueled its ambitions beyond COVID-19.
AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.